SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-672020
Filing Date
2016-08-04
Accepted
2016-08-04 17:20:04
Documents
84
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d211534d10q.htm 10-Q 596823
2 EX-31.1 d211534dex311.htm EX-31.1 8753
3 EX-31.2 d211534dex312.htm EX-31.2 8715
4 EX-32.1 d211534dex321.htm EX-32.1 3774
  Complete submission text file 0001193125-16-672020.txt   4133091

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT lnth-20160630.xml EX-101.INS 741245
6 XBRL TAXONOMY EXTENSION SCHEMA lnth-20160630.xsd EX-101.SCH 57013
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lnth-20160630_cal.xml EX-101.CAL 92410
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lnth-20160630_def.xml EX-101.DEF 164561
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE lnth-20160630_lab.xml EX-101.LAB 409409
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lnth-20160630_pre.xml EX-101.PRE 295215
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

IRS No.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36569 | Film No.: 161808446
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences